Rhabdomyosarcoma medical therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 6: | Line 6: | ||
All patients with rhabdomyosarcoma require multimodality therapy with systemic [[chemotherapy]], in conjunction with either surgery, [[radiation therapy]] (RT), or both modalities to maximize local tumor control. | All patients with rhabdomyosarcoma require multimodality therapy with systemic [[chemotherapy]], in conjunction with either surgery, [[radiation therapy]] (RT), or both modalities to maximize local tumor control. | ||
===Chemotherapy=== | ===Chemotherapy=== | ||
Common agents include: | Chemotherapy may be given as [[neoadjuvant chemotherapy]] or [[adjuvant chemotherapy]]. Common agents include: | ||
*[[Vincristine]] | *[[Vincristine]] | ||
*[[Cyclophosphamide]] | *[[Cyclophosphamide]] | ||
| Line 14: | Line 14: | ||
*VP-16 | *VP-16 | ||
===Raditherapy=== | ===Raditherapy=== | ||
*[[External beam radiation]] is used in some cases of rhabdomyosarcoma. | *[[Radiation|External beam radiation]] is used in some cases of rhabdomyosarcoma. | ||
Revision as of 19:24, 4 September 2015
|
Rhabdomyosarcoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Rhabdomyosarcoma medical therapy On the Web |
|
American Roentgen Ray Society Images of Rhabdomyosarcoma medical therapy |
|
Risk calculators and risk factors for Rhabdomyosarcoma medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Medical Therapy
All patients with rhabdomyosarcoma require multimodality therapy with systemic chemotherapy, in conjunction with either surgery, radiation therapy (RT), or both modalities to maximize local tumor control.
Chemotherapy
Chemotherapy may be given as neoadjuvant chemotherapy or adjuvant chemotherapy. Common agents include:
Raditherapy
- External beam radiation is used in some cases of rhabdomyosarcoma.